FNY Managed Accounts’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-93	Closed	-$27K	–	757
2017 Q4	$27K	Buy	+93	New	+$27K	0.02%	101